It's got a big name — bapineuzumab — but a new Alzheimer's drug could also have a big payoff. With projections in the billions, it could be the highest grossing drug in history. Janet Babin reports.
A new drug called bapineuzumab has potential to be a strong weapon against Alzheimer's disease. While risks are still being assessed, drug sales could hit $3 billion if the final trial goes well. Janet Babin reports.
Oil and food prices are climbing to staggering heights, but some analysts say if you look at core inflation, which excludes food and energy, the spikes aren't as upsetting. Janet Babin reports.
Census data show a lot of people mark their career as "artist." What does it take to be an artist and how true are the stereotypes? Janet Babin reports.
Retailer Gap Inc. plans to consolidate its various specialty stores into its main stores to save on real estate costs and unite its brand. Janet Babin reports.
Grocery stores and restaurants are rushing to remove tomatoes as salmonella fears spread and regulators try to figure out where the bacteria came from and how to stop it. Janet Babin reports.
Even with an impressive skill set, many Iraqi refugees have trouble finding jobs in the U.S. To help, a nonprofit group in Washington, D.C. is working to help bridge the communication gap. Janet Babin has more.
The world's largest and oldest contemporary art fair is underway in Switzerland, and despite harder economic times, the art market is actually doing pretty well. Janet Babin tells us who's been coming to the show.
Time Warner Cable is testing out a new price structure for high-speed Internet access in a small town in Texas where the more you download, the more you pay. Janet Babin reports some consumer watchdogs find the model unfair.
Make room for science at the dinner table. One San Diego company is grabbing its share of the multibillion-dollar flavor market. Janet Babin visits and takes us on the search for the perfect taste.
